Keyphrases
Active Treatment
3%
Age 50
3%
Benign Prostatic Hyperplasia
100%
Certainty of Evidence
6%
Cochrane
3%
Comparative Effectiveness
3%
Comprehensive Search
3%
Conference Proceedings
3%
Confidence Interval
100%
Continuous Data
3%
Dichotomous Data
3%
Ejaculatory Dysfunction
6%
Ejaculatory Function
6%
Embase
3%
Erectile Function
17%
Extended Follow-up
3%
Extracted Data
3%
Frequentist Network Meta-analysis
3%
GRADE Approach
3%
Group Randomized Controlled Trial
3%
High-score
10%
IIEF-5
3%
Incoherence
3%
Inconsistency
3%
International Index of Erectile Function
3%
International Prostate Symptom Score
6%
Language of Publication
3%
Large Reduction
6%
Lower Urinary Tract Symptoms
100%
Major Adverse Events
20%
MEDLINE
3%
Minimally Invasive Procedures
3%
Minimally Invasive Treatment
100%
Moderate to Severe
3%
Multiple Databases
3%
Network Meta-analysis
100%
Pairwise Comparison
3%
Prostate Treatment
3%
Prostate Volume
3%
Prostatic Arterial Embolization
44%
Prostatic Urethral Lift
55%
Publication Status
3%
Quality of Life
13%
Quality of Life Assessment
6%
Radio Frequency
31%
Random Effects Model
3%
Relative Effectiveness
3%
Relative Rank
3%
Retreatment
17%
Retreatment Rate
6%
Review Authors
3%
Risk of Bias
3%
Risk Ratio
41%
Scopus
3%
Search Methods
3%
Selection Criteria
3%
Sexual Behavior
3%
Sham Treatment
3%
Short-term Follow-up
6%
Statistical Analysis
3%
Subgroup Analysis
3%
Symptom Score
10%
Temporary Implantable Nitinol Device
31%
Transurethral Microwave Thermotherapy
34%
Transurethral Resection of Prostate
34%
Treatment Modalities
3%
Trial Registries
3%
Urinary Symptoms
10%
Urologic Symptoms
10%
Water Vapor Therapy
31%
Web of Science
3%
Medicine and Dentistry
Adverse Event
46%
Arterial Embolization
100%
Inhalational Drug Administration
69%
International Index of Erectile Function
7%
International Prostate Symptom Score
15%
Lower Urinary Tract Symptom
100%
Minimally Invasive Procedure
100%
Network Meta-Analysis
100%
Nitinol
69%
Prostate Hypertrophy
100%
Quality of Life
46%
Random Effects Model
7%
Randomized Controlled Trial
7%
Retreatment
53%
Sham Procedure
7%
Subgroup Analysis
7%
Transurethral Microwave Thermotherapy
76%
Transurethral Resection
76%
Urinary System
23%
Pharmacology, Toxicology and Pharmaceutical Science
Adverse Event
66%
Lower Urinary Tract Symptom
100%
Nitinol
100%
Prostate Hypertrophy
100%
Random Effects Model
11%
Randomized Controlled Trial
11%
Agricultural and Biological Sciences
Confidence Interval
100%
Meta-Analysis
100%
Quality of Life
20%
Selection Criterion
3%
Spider Web
3%
Urinary System
100%
Neuroscience
Hyperplasia
100%
Meta-Analysis
100%
Prostate
20%
Randomized Controlled Trial
20%